Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started
My Medicine

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Font Size

Predicting Prostate Cancer Death

Rapid Rise in PSA Levels Even Years Before Diagnosis May Foretell Outcome

Controversial Test continued...

But it is now known that men with PSA levels under 4.0 can have prostate cancercancer; and it is increasingly clear that a single PSA reading usually doesn't tell the whole story, Carter says.

"There is no single PSA level that can be used to determine if someone needs a biopsy," he says.

A better approach, Carter says, is to test PSA at regular intervals to determine how fast levels are rising.

He suggests men have a baseline PSA at age 40, with the timing of repeat tests determined by that PSA and other risk factors.

In the Johns Hopkins study, men with a PSA velocity above 0.35 per year – meaning their PSA level rose more than that per year -- were five times more likely to die of prostate cancer 25 years later than men with a slower rise in PSA.

The study is published in the Nov. 1 issue of the Journal of the National Cancer Institute.

Prognostic Potential

The hope is that if used in this new way, PSA testing will help doctors better distinguish between men with prostate cancer who will die without treatment and those who will not.

Prostate cancer researcher Timothy R. Church, PhD, says larger studies under way will help determine if PSA velocity can help predict prognosis.

Until the results of those studies are known, generalized guidelines regarding PSA screening are not possible, Church says.

"At this point it really comes down to a conversation between the patient and his medical care provider," Carter tells WebMD. "It is not a simple decision."

1 | 2

Today on WebMD

man with doctor
Symptoms, risks, treatments
man coughing
Men shouldn’t ignore
prostate cancer cells
What does this diagnosis mean?
doctor and male patient
Is it worth it?
cancer fighting foods
15 Cancer Symptoms Men Ignore
Prostate Enlarged
Picture Of The Prostate
Prostate Cancer Quiz
screening tests for men
Prostate Cancer Symptoms
Vitamin D